The cancer gene therapy market's growth is propelled by rising R&D investments, increasing cancer incidence, and supportive regulations. Key opportunities lie in advancements in immunotherapy and ...
A study led by Vincenzo Condello and Christofer Juhlin of the Karolinska Institutet explores why some papillary thyroid ...
News-Medical.Net on MSN
Gene expression test identifies prostate cancer patients who benefit from hormone therapy
A new randomized study finds that a lab test that reads tumor genes can identify which patients with recurrent prostate ...
Researchers at the University of Oslo and Oslo University Hospital have developed a promising new immunotherapy targeting the ...
Pharmaceutical Technology on MSN
Imunon’s Phase III-stage IL-12 gene therapy alters tumour microenvironment in ovarian cancer
Bucking the trend of IL-12 therapy programme failures, Imunon’s IMNN-001 was bolstered by positive translational data in ...
M&A headlined for a second straight week as Genmab acquired Merus for $8 billion; Pfizer strikes most-favored-nation deal ...
From cancer biology to proactive health management, customized care is changing patient outcomes, but what are the costs and ...
The Brighterside of News on MSN
AI-powered CRISPR technology turbocharges gene therapy development
Stanford researchers and their collaborators have revealed a new device that could change the way scientists conduct ...
It's a test of CEO Bill Anderson's development credentials as patent expiries on blockbuster drugs threaten the group's ...
Breast cancer awareness campaigns often focus on mammograms and self-exams. But there's another critical piece of the puzzle, ...
Gene Solutions, a leading genetic testing innovator in Asia, has partnered with AMPATH (American Institute of Pathology and ...
A genetic test could guide the use of hormone therapy for men with recurrent prostate cancer after surgery, according to data ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback